|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Drug Discovery Informatics 2003 | ||||||||||||||||
| July 08, 2003 | ||||||||||||||||
|
Worldwide Business Research Ltd, Mainz, Germany 2003-09-24 Day 1 09:00 Delivering Bioinformatics Solutions To The Forefront Of The Drug Discovery Process 09:30 An Analysis Of Systems Biology In Drug Discovery: Evaluating The Applications Of A Computational Model Of ErbB Signaling In Cancer Therapy 10:00 Recent Innovation In The Use And Understanding Of Proteomics And Bioinformatics: The Case Of Anticancer Drug 11:00 Intergrated High Throughput Systems And Bioinformatics - From Sample To Silicon 11:30 Antibody Microarrays – A New Type Of Microarray For The Multiplexed, Quantitative And Sensitive Measurement Of Protein Concentrations 12:00 What Are The Most Crucial Problems That We Need To Overcome In Order To Make The Pharmaceutical & Biotech Pipeline Fully Efficient? Then Split for 2 Streams: Day 2 09:00 A Critical Analysis Of vHTS, High Performance Computing And The Impact Of XML On The Drug Discovery And Development Processes 09:30 Evaluating Measures Needed To Maximise Returns On Genomics Investments Through The Use Of Informatics 11:00 Evaluating The Most Efficient Means To Characterise Proteins So As To Fully And Efficiently Understand The Data And Information Involved 11:30 Then Split for 2 Streams:
|
||||||||||||||||
| Organized by: | Worldwide Business Research Ltd | |||||||||||||||
| Invited Speakers: | Adrian Bruengger, Laboratory Head Of Bioinformatics, Lead Discovery Centre, NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH Jack Beusmans, Lead Scientist, Pathway Modeling, ASTRAZENECA R&D BOSTON Ananda Chakrabarty, Distinguished University Professor, UNIVERSITY OF ILLINOIS AT CHICAGO John Hassard, CEO, DELTA DOT John Peden, Thomas Busl, Head of Bioinformatics, XERION PHARMACEUTICALS Simon Brocklehurst, Director of Informatics & Robotics, CAMBRIDGE ANTIBODY TECHNOLOGY Dirk Ullmann, Director of Biology Services, EVOTEC OAI Roland Dunbrack, Jr, Assistant Professor, INSTITUTE FOR CANCER RESEARCH, FOX CHASE CANCER CENTER Andreas Ladurner, Group Leader Gene Expression, EMBL Jens Meiler, Head of Biochemistry, UNIVERSITY OF WASHINGTON Richard Scott, Head of Discovery Informatics, DE NOVO PHARMACEUTICALS John Overington, Vice President, Drug Discovery, INPHARMATICA Sanjay Kapoor, Medical Information Manager, ALTANA PHARMA Frederique Lisasek, Chief Scientific Officer, GENEBIO Antonello Covacci, Head of Bioinformatics, CHIRON Nick Lemoine, Director of Molecular Oncology, CANCER RESEARCH UK & IMPERIAL COLLEGE LONDON Michael Primig, Assistant Professor,BIOZENTRUM & SWISS INSTITUTE OF BIOINFORMATICS Vladimir Poroikov,Head of Laboratory for Structure-Function Based Drug Design,INSTITUTE OF BIOMEDICAL CHEMISTRY OF RUSSIAN ACADEMY OF MEDICAL SCIENCE Juergen Klenk,Chief Technical Officer,DEFINIENS Pekka Uimari, Head of Bioinformatics, JURILAB Hans Dieter Zucht, Director of Bioinformatics, BIOVISION Matthias Steger,Head of Combinatorial Chemistry, AXOVAN
|
|||||||||||||||
| Deadline for Abstracts: | 2003-07-18 | |||||||||||||||
| Registration: | ||||||||||||||||
| E-mail: | colin17@wbr.co.uk | |||||||||||||||
| Posted by: | Colin Chapman | |||||||||||||||
| Host: | mail.wbr.co.uk | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||